• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT 2.40% 64.0¢

OPTHEA LIMITED

Opthea Limited is an Australia-based biotechnology company. The Company is engaged in the... Opthea Limited is an Australia-based biotechnology company. The Company is engaged in the development and commercialization of therapies primarily for eye disease. The Company’s lead asset, OPT-302, is a novel biologic inhibitor of VEGF-C and VEGF-D, for use in combination with VEGF-A inhibitors for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The Company’s principal activities include the progression of the Company’s Phase III registration trials of OPT-302 for wet AMD. It also manufactures OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. The Company’s development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OPT
Hang in there!!
2 3
29/04/24 155 66K
29/04/24 Last post  whytee Comments Created with Sketch.  155  Views Created with Sketch.  66K 
OPT 26/04/24 0 301
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  301 
OPT
Opthea Chart
4 5 6
16/04/24 309 168K
Consumer Defensive SECTOR NEWS

Discover how The Calmer Co. is setting the pace in the fast-growing natural health sector!

CCO
29 Apr 2024
THE CALMER CO INTERNATIONAL LIMITED
16/04/24 Last post  willxue123 Comments Created with Sketch.  309  Views Created with Sketch.  168K 
OPT 15/04/24 34 7.6K
15/04/24 Last post  whytee Comments Created with Sketch.  34  Views Created with Sketch.  7.6K 
OPT 15/04/24 0 213
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  213 
OPT 15/04/24 0 182
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  182 
OPT 09/04/24 9 2.3K
09/04/24 Last post  flotsam222 Comments Created with Sketch.  9  Views Created with Sketch.  2.3K 
OPT 08/04/24 3 1.6K
08/04/24 Last post  gmutton Comments Created with Sketch.  3  Views Created with Sketch.  1.6K 

See All Discussions arrow Created with Sketch.

Timeline

Opthea Presents at the OIS Retina Innovation Summit at ARVO
26 Apr 08:17
 
Notification regarding unquoted securities - OPT
15 Apr 11:19
 
Notification regarding unquoted securities - OPT
15 Apr 10:54
 
Opthea Appoints John Han, PharmD, as VP Medical Affairs
09 Apr 08:23
 
Opthea Corporate Presentation - April 2024
05 Apr 09:34
 
Opteha to Participate in the 23rd Needham Virtual Conference
05 Apr 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
64.0¢
Change
0.015(2.40%)
Mkt cap ! $424.1M
Open High Low Value Volume
64.5¢ 67.0¢ 64.0¢ $138.1K 211.7K

Buyers (Bids)

No. Vol. Price($)
1 4904 64.0¢
 

Sellers (Offers)

Price($) Vol. No.
65.0¢ 43573 1
View Market Depth
Last trade - 16.10pm 29/04/2024 (20 minute delay) ?
Last
64.0¢
  Change
0.015 ( 2.84 %)
Open High Low Volume
65.0¢ 66.5¢ 64.0¢ 39023
Last updated 15.59pm 29/04/2024 ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.